CD40:CD154 interactions and allograft rejection
- 1 March 2000
- journal article
- mechanics of-rejection
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 5 (1) , 10-15
- https://doi.org/10.1097/00075200-200003000-00003
Abstract
An area of considerable interest in current transplantation immunology is the role of costimulatory molecules in the development of the immune response. One specific costimulatory receptor:ligand interaction that has been the object of extensive investigation is that of CD40:CD154. This interaction has been implicated in T cell and antigen-presenting cell activation, and in the pathogenesis of allograft rejection. This review examines recent progress made in our understanding of these important costimulatory molecules, and their potential relevance to therapeutic immunosuppression.Keywords
This publication has 42 references indexed in Scilit:
- CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejectionKidney International, 1999
- Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibodyDiabetes, 1998
- Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysNature, 1996
- Human Native Soluble CD40L Is a Biologically Active Trimer, Processed Inside MicrosomesPublished by Elsevier ,1996
- CD40-gp39 INTERACTIONS PLAY A CRITICAL ROLE DURING ALLOGRAFT REJECTIONTransplantation, 1996
- Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.The Journal of Experimental Medicine, 1995
- CD40 ligand-transduced co-stimulation of T cells in the development of helper functionNature, 1995
- Humoral immune responses in CD40 ligand-deficient mice.The Journal of Experimental Medicine, 1994
- Mice deficient for the CD40 ligandPublished by Elsevier ,1994
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993